Navigation Links
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results
Date:5/3/2011

to $1.3 million in the corresponding period in 2010.Cash and Investments:  As of March 31, 2011, Lexicon had $188.9 million in cash and investments, as compared to $211.1 million as of December 31, 2010.  

Lexicon Conference Call:Lexicon management will hold a conference call to discuss financial results for the first quarter of 2011 and program status at 11:00 a.m. Eastern Time on May 3, 2011.  The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international).  The conference ID for all callers is 62216935.  An archived version of the conference call will be available on Lexicon's corporate website at www.lexpharma.com through May 31, 2011.

About LexiconLexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor StatementThis press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX1031, LX1032, LX1033, LX2931, and LX4211, including characterizations of the results of and projected timing of clinical trials of such compounds, and the potential therapeutic and commercial potential of LX1031, LX1032, LX1033, LX2931, and LX4211. This press release also contains forward-lo
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Lexicon to Provide First Quarter 2011 Financial Results
2. Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
3. Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
5. Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
6. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
7. Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare Conference
8. Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
9. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
10. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
11. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  Decision Resources Group finds that the Asia Pacific ... China , India , ... through 2023. Dental implant procedure volumes will grow as physicians are ... Other key findings from Decision Resources Group,s coverage of the ... , Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... 2014 A study using a relatively new ... look at the composition of carotid artery disease and ... treat the disease, a leading cause of stroke. ... between September 2010 and May 2012, was featured in ... the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... BEACH, Calif. , Sept. 30, 2014 /PRNewswire-USNewswire/ ... accreditation of the American Association of Tissue Banks ... Cook , Chief Executive Officer. Accreditation ... inspection by a specially trained AATB inspector.  It ... administrative performance within the facility meets or exceeds ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Biostructures, LLC Earns AATB Accreditation 2
... Oct. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ... researching, developing, manufacturing and marketing,biopharmaceutical products, today announced the ... October 12, 2009. , At ... and Mr.,Moujia Qi to serve as members of the ...
... used to treat high blood pressure appear to be effective ... stable ischemic heart disease, according to a new comparative effectiveness ... A version of the analysis was posted in the ... Medicine . , Treatment featuring the two medications -- inhibitors ...
Cached Medicine Technology:High Blood Pressure Medicines Show Promise For Treating Heart Disease 2High Blood Pressure Medicines Show Promise For Treating Heart Disease 3
(Date:9/30/2014)... 2014 (HealthDay News) -- Sleep apnea is a potential health ... to a possible culprit behind the disorder: a "fat" tongue. ... deposits are increased in the tongue of obese patients with ... of the Sleep Center at the University of Pennsylvania Medical ... which will publish the findings Oct. 1. Sleep apnea ...
(Date:9/30/2014)... SILVERTHORNE, CO September 30, 2014 Keystone Symposia ... and the first in its 2014-15 Global Health Series ... at the Sheraton Seattle Hotel immediately following the ... grantees. The four-day conference is part of the Keystone ... Melinda Gates Foundation, which has also funded travel awards ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Dynamic ... have hampered growth in the Bread Production industry ... caused consumers to moderate their consumption of a ... for premium varieties shrunk the market for white ... operators proactively responded by introducing more nutritious products ...
(Date:9/30/2014)... Research by UC Irvine immunologists reveals new information ... a vital process that determines how the body,s ability ... of Nature Immunology , neurology professor Dr. Michael ... Immunology colleagues describe a critical mechanism underlying how T ... , A T cell is a type of blood ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Glycodrive ... Star Nutraceuticals designed to help maximize lean, strong muscle ... the body’s absorption of glucose has caught the attention ... “The main purpose behind Glycodrive is to help the ... muscle,” reports Michaels. “Carbs are essential in the muscle-building ...
Breaking Medicine News(10 mins):Health News:Could a 'Fat Tongue' Be a Factor in Sleep Apnea? 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:UCI study uncovers important process for immune system development 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2
... One-fourth of overweight children may have sleep problems that ... ,Research published in the November issue of Obesity ... children tested positive for sleep-disordered breathing, including telltale snoring. ... after-school physical activity such as jumping rope, basketball and ...
... a dearth of specialists, which was confirmed by the Hospital ... the hospital will have to put up with the shortfall ... services is currently on leave. The hospital is in the ... , ,The medical board is also ...
... and cynical exploitation” by the alternative medicines industry, argues a ... estimated that up to 80% of all patients with cancer ... help treat their cancer, writes Jonathan Waxman, Professor of Oncology ... the use of many of these approaches is obtuse – ...
... study on schizophrenic patients has come up with a finding ... anti-psychotic drugs. // ,The study was conducted upon ... the treatment they were getting was ineffective. They were then ... on new. Experienced doctors decided which type of anti–psychotic drug ...
... examination of 4 cases of botulism following cosmetic injections ... highly concentrated, //unlicensed preparation that resulted in toxin levels ... according to a report. ,Botulism is a rare ... bacterium Clostridium botulinum and toxin-producing strains of Clostridium baratii ...
... in on cardiac master cells that could develop into ... groups of researchers who have been putting their independent ... teams from Massachusetts General Hospital have recognized a variety ... this could develop into cardiac muscle, endothelial cells or ...
Cached Medicine News:Health News:Sleep Problems in Overweight Children Appear Fairly Common 2Health News:Sleep Problems in Overweight Children Appear Fairly Common 3Health News:Protect Patients from Exploitation by Alternative Medicines Industry, Says Expert 2Health News:Old Anti-psychotic Drugs Are Equally Good 2Health News:Highly-Concentrated Botulinum Preparation Can Result in Severe Illness 2Health News:Highly-Concentrated Botulinum Preparation Can Result in Severe Illness 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: